NetworkNewsBreaks – EnteroMedics, Inc. (NASDAQ: ETRM) Shares Surge on First vBloc® Neurometabolic Therapy Implant
EnteroMedics (NASDAQ: ETRM) shares are up 12% late-morning following news that the first implant of the company's vBloc® Neurometabolic Therapy was successfully completed at the McGuire Veterans Affairs Medical Center (Richmond VAMC) in Richmond, Virginia, earlier this week. The pacemaker-like device works to control sensations of hunger to enable patients to control their appetite and lose weight. "With our first implant at the Richmond VAMC, we are making vBloc accessible to an even larger portion of the men and women who have served our country selflessly and are in need of solutions to address their obesity. Through our previously announced…